{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:02:57Z","timestamp":1793037777963,"version":"4.5.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>A commonly used guideline for community-acquired pneumonia (CAP) is the joint American Thoracic Society and Infectious Diseases Society of America practice guideline. We aimed to investigate the effect of guideline-concordant therapy in the treatment of CAP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We systematically searched MEDLINE, Embase, CENTRAL, Web of Science, and Scopus from 2007 to December 2023. We screened citations, extracted data, and assessed risk of bias in duplicate. Primary outcomes were mortality rates, intensive care unit (ICU) admission, and length of stay. Secondary outcomes were guideline adherence, readmission, clinical cure rate, and adverse complications. We performed random-effect meta-analysis to estimate the overall effect size and assessed heterogeneity using the I2 statistics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We included 17 observational studies and 82 240 patients, of which 10 studies were comparative and pooled in meta-analysis. Overall guideline adherence rate was 65.2%. Guideline-concordant therapy was associated with a statistically significant reduction in 30-day mortality rate (crude odds ratio [OR], 0.49 [95% confidence interval .34\u2013.70; I2 = 60%]; adjusted OR, 0.49 [.37\u2013.65; I2 = 52%]) and in-hospital mortality rate (crude OR, 0.63 [.43\u2013.92]; I2 = 61%). Due to significant heterogeneity, we could not assess the effect of guideline-concordant therapy on length of stay, ICU admission, readmission, clinical cure rate, and adverse complications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In hospitalized patients with CAP, guideline-concordant therapy was associated with a significant reduction in mortality rate compared with nonconcordant therapy; however, there was limited evidence to support guideline-concordant therapy for other clinical outcomes. Future studies are needed to assess the clinical efficacy and safety of current guideline recommendations.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofae336","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:19:37Z","timestamp":1718237977000},"source":"Crossref","is-referenced-by-count":10,"title":["Guideline-Concordant Therapy for Community-Acquired Pneumonia in the Hospitalized Population: A Systematic Review and Meta-analysis"],"prefix":"10.1093","volume":"11","author":[{"given":"Chanhee","family":"Seo","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Calgary , Calgary, Alberta , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Corrado","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary , Calgary, Alberta , Canada"},{"name":"Division of Respiratory Medicine, Department of Medicine, University of Calgary , Calgary, Alberta , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-6211","authenticated-orcid":false,"given":"Christina S","family":"Thornton","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary , Calgary, Alberta , Canada"},{"name":"Division of Respiratory Medicine, Department of Medicine, University of Calgary , Calgary, Alberta , Canada"},{"name":"Department of Microbiology, Immunology and Infectious Diseases, University of Calgary , Calgary, Alberta , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,15]]},"reference":[{"key":"2024072916005038200_ofae336-B1","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S1473-3099(17)30396-1","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the global burden of disease study 2015","volume":"17","author":"Troeger","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"suppl 6","key":"2024072916005038200_ofae336-B2","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections\u2014full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"suppl 2","key":"2024072916005038200_ofae336-B3","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2024072916005038200_ofae336-B4","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 3","key":"2024072916005038200_ofae336-B5","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1136\/thx.2009.121434","article-title":"BTS guidelines for the management of community acquired pneumonia in adults: update 2009","volume":"64","author":"Lim","year":"2009","journal-title":"Thorax"},{"key":"2024072916005038200_ofae336-B6","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archinternmed.2009.259","article-title":"Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules","volume":"169","author":"McCabe","year":"2009","journal-title":"Arch Intern Med"},{"key":"2024072916005038200_ofae336-B7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.clinthera.2010.02.006","article-title":"Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit","volume":"32","author":"Frei","year":"2010","journal-title":"Clin Ther"},{"key":"2024072916005038200_ofae336-B8","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/jac\/dkr176","article-title":"Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia","volume":"66","author":"Grenier","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2024072916005038200_ofae336-B9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2466-14-7","article-title":"Non-invasive mechanical ventilation and mortality in elderly immunocompromised patients hospitalized with pneumonia: a retrospective cohort study","volume":"14","author":"Johnson","year":"2014","journal-title":"BMC Pulm Med"},{"key":"2024072916005038200_ofae336-B10","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.chest.2020.07.089","article-title":"International perspective on the new 2019 American Thoracic Society\/Infectious Diseases Society of America community-acquired pneumonia guideline: a critical appraisal by a global expert panel","volume":"158","author":"Pletz","year":"2020","journal-title":"Chest"},{"key":"2024072916005038200_ofae336-B11","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred Reporting Items for Systematic Review and Meta-analysis Protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"2024072916005038200_ofae336-B12","author":"Higgins"},{"key":"2024072916005038200_ofae336-B13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2024072916005038200_ofae336-B14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2024072916005038200_ofae336-B15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"2024072916005038200_ofae336-B16","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"2024072916005038200_ofae336-B17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","article-title":"The case of the misleading funnel plot","volume":"333","author":"Lau","year":"2006","journal-title":"BMJ"},{"key":"2024072916005038200_ofae336-B18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/j.2055-2335.2013.tb00273.x","article-title":"Adherence to guidelines for treating community-acquired pneumonia at a New Zealand hospital","volume":"43","author":"Aikman","year":"2013","journal-title":"J Pharm Pract Res"},{"key":"2024072916005038200_ofae336-B19","doi-asserted-by":"crossref","first-page":"101678","DOI":"10.1016\/j.jsps.2023.06.011","article-title":"Adherence to evidence-based guidelines for the management of pneumonia in a tertiary teaching hospital in Riyadh","volume":"31","author":"Alessa","year":"2023","journal-title":"Saudi Pharm J"},{"key":"2024072916005038200_ofae336-B20","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/archinternmed.2009.265","article-title":"Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: community-acquired pneumonia organization international cohort study results","volume":"169","author":"Arnold","year":"2009","journal-title":"Arch Intern Med"},{"key":"2024072916005038200_ofae336-B21","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1164\/rccm.201502-0212OC","article-title":"The effect of macrolide resistance on the presentation and outcome of patients hospitalized for Streptococcus pneumoniae pneumonia","volume":"191","author":"Cilloniz","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2024072916005038200_ofae336-B22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2169\/internalmedicine.52.8830","article-title":"Etiology and factors contributing to the severity and mortality of community-acquired pneumonia","volume":"52","author":"Ishiguro","year":"2013","journal-title":"Intern Med"},{"key":"2024072916005038200_ofae336-B23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamainternmed.2019.7495","article-title":"Empirical anti-MRSA vs standard antibiotic therapy and risk of 30-day mortality in patients hospitalized for pneumonia","volume":"180","author":"Jones","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2024072916005038200_ofae336-B24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12873-021-00505-4","article-title":"Antibiotic prescription consistent with guidelines in emergency department is associated with 30-day survival in severe community-acquired pneumonia","volume":"21","author":"Kang","year":"2021","journal-title":"BMC Emerg Med"},{"key":"2024072916005038200_ofae336-B25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijid.2022.09.015","article-title":"Extended-spectrum antibiotics for community-acquired pneumonia with a low risk for drug-resistant pathogens","volume":"124","author":"Kobayashi","year":"2022","journal-title":"Int J Infect Dis"},{"key":"2024072916005038200_ofae336-B26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3855\/jidc.2834","article-title":"Impact of infectious etiology on the outcome of Taiwanese patients hospitalized with community acquired pneumonia","volume":"7","author":"Lee","year":"2013","journal-title":"J Infect Dev Ctries"},{"key":"2024072916005038200_ofae336-B27","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00134-009-1730-y","article-title":"Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia","volume":"36","author":"Martin-Loeches","year":"2010","journal-title":"Intensive Care Med"},{"key":"2024072916005038200_ofae336-B28","doi-asserted-by":"crossref","first-page":"e000554","DOI":"10.1136\/bmjoq-2018-000554","article-title":"AMS in the ICU: empiric therapy and adherence to guidelines for pneumonia","volume":"8","author":"Pflanzner","year":"2019","journal-title":"BMJ Open Qual"},{"key":"2024072916005038200_ofae336-B29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10096-016-2779-5","article-title":"Improved survival among ICU-hospitalized patients with community-acquired pneumonia by unidentified organisms: a multicenter case\u2013control study","volume":"36","author":"Rello","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024072916005038200_ofae336-B30","first-page":"876","article-title":"Electronic quality measurement predicts outcomes in community acquired pneumonia","volume":"2012","author":"Sims","year":"2012","journal-title":"AMIA Annu Symp Proc"},{"key":"2024072916005038200_ofae336-B31","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/jac\/dku533","article-title":"Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia","volume":"70","author":"Rothberg","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2024072916005038200_ofae336-B32","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1183\/09031936.00141110","article-title":"Guideline-concordant therapy and outcomes in healthcare-associated pneumonia","volume":"38","author":"Attridge","year":"2011","journal-title":"Eur Respir J"},{"key":"2024072916005038200_ofae336-B33","doi-asserted-by":"crossref","first-page":"e202899","DOI":"10.1001\/jamanetworkopen.2020.2899","article-title":"Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use","volume":"3","author":"Rhee","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2024072916005038200_ofae336-B34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"2024072916005038200_ofae336-B35","doi-asserted-by":"crossref","first-page":"886","DOI":"10.12788\/jhm.2877","article-title":"Treatment trends and outcomes in healthcare-associated pneumonia","volume":"12","author":"Haessler","year":"2017","journal-title":"J Hosp Med"},{"key":"2024072916005038200_ofae336-B36","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/cid\/civ629","article-title":"Trends in antibiotic use and nosocomial pathogens in hospitalized veterans with pneumonia at 128 medical centers, 2006\u20132010","volume":"61","author":"Jones","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2024072916005038200_ofae336-B37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12879-019-4048-6","article-title":"Usefulness of sputum Gram stain for etiologic diagnosis in community-acquired pneumonia: a systematic review and meta-analysis","volume":"19","author":"Del Rio-Pertuz","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2024072916005038200_ofae336-B38","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/thx.2004.030411","article-title":"Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study","volume":"60","author":"van der Eerden","year":"2005","journal-title":"Thorax"},{"key":"2024072916005038200_ofae336-B39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/trstmh\/tru058","article-title":"The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review","volume":"108","author":"Peto","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2024072916005038200_ofae336-B40","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.162.16.1849","article-title":"Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis","volume":"162","author":"Arancibia","year":"2002","journal-title":"Arch Intern Med"},{"key":"2024072916005038200_ofae336-B41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1164\/ajrccm.160.2.9808045","article-title":"Etiology of community-acquired pneumonia","volume":"160","author":"Ruiz","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2024072916005038200_ofae336-B42","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/thx.2010.143982","article-title":"Microbial aetiology of community-acquired pneumonia and its relation to severity","volume":"66","author":"Cilloniz","year":"2011","journal-title":"Thorax"},{"key":"2024072916005038200_ofae336-B43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/mdr.1995.1.115","article-title":"Pneumococcal resistance to \u03b2-lactam antibiotics: a global geographic overview","volume":"1","author":"Baquero","year":"1995","journal-title":"Microb Drug Resist"},{"issue":"suppl 2","key":"2024072916005038200_ofae336-B44","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/320181","article-title":"Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY antimicrobial surveillance program, 1997\u20131999","volume":"32","author":"Hoban","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2024072916005038200_ofae336-B45","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1128\/AAC.05658-11","article-title":"Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study","volume":"56","author":"Kim","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2024072916005038200_ofae336-B46","doi-asserted-by":"crossref","first-page":"h870","DOI":"10.1136\/bmj.h870","article-title":"Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients","volume":"350","author":"Iorio","year":"2015","journal-title":"BMJ"},{"key":"2024072916005038200_ofae336-B47","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2147\/COPD.S83135","article-title":"Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population","volume":"10","author":"Kern","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024072916005038200_ofae336-B48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41479-020-00068-1","article-title":"Validation for using electronic health records to identify community acquired pneumonia hospitalization among people with and without HIV","volume":"12","author":"Rodriguez-Barradas","year":"2020","journal-title":"Pneumonia"},{"key":"2024072916005038200_ofae336-B49","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.annepidem.2013.02.005","article-title":"Accuracy of ICD-9-CM codes in identifying infections of pneumonia and herpes simplex virus in administrative data","volume":"23","author":"Drahos","year":"2013","journal-title":"Ann Epidemiol"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae336\/58241191\/ofae336.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/7\/ofae336\/58626366\/ofae336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/7\/ofae336\/58626366\/ofae336.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:02:29Z","timestamp":1722297749000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae336\/7693889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,6,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae336","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,6,15]]},"article-number":"ofae336"}}